Sanofi
Sanofi is a global healthcare company based in France, specializing in pharmaceuticals and vaccines. It is committed to addressing healthcare challenges and has a history of stable dividend payments, reflecting its strong financial performance.
Not in the pool (under ¢1).
Recent news mentions
Sanofi is mentioned as a prominent pharmaceutical company involved in the China-Europe business landscape.
歐陽五：中歐關係 多按綠燈 - 20250729 - 觀點 - 每日明報
Hong Kong· 2025-07-29
Sanofi continues to operate in Ukraine even during the full-scale war, providing essential medical supplies and support.
Як працюють міжнародні фармкомпанії в Україні: досвід Санофі
Ukraine· 2025-06-25France’s Sanofi has said it wants to invest at least $20 billion through 2030.
Brussels seeks detail on companies’ U.S. investment plans ahead of trade talks
Canada· 2025-05-27
Sanofi is a French pharmaceutical company that announced its intention to invest at least $20 billion in the United States over the next five years.
Sanofi promet d’investir 20 milliards de dollars aux Etats-Unis
France· 2025-05-14
Sanofi announced the finalization of the sale of 50% of Opella, the parent company of Doliprane.
Doliprane : Sanofi finalise la vente d’Opella pour 10 milliards d’eurosFrance· 2025-04-30
Sanofi is recognized for its long-standing commitment to increasing dividends.
Dividenden als Rendite-Booster: Ausschüttungen treiben Börsenkurse
Switzerland· 2025-03-01
